332 related articles for article (PubMed ID: 26979993)
41. Atypical FTLD-FUS associated with ALS-TDP: a case report.
Kobayashi Z; Arai T; Yokota O; Tsuchiya K; Hosokawa M; Oshima K; Niizato K; Akiyama H; Mizusawa H
Neuropathology; 2013 Feb; 33(1):83-6. PubMed ID: 22640227
[TBL] [Abstract][Full Text] [Related]
42. hnRNP A3 binds to GGGGCC repeats and is a constituent of p62-positive/TDP43-negative inclusions in the hippocampus of patients with C9orf72 mutations.
Mori K; Lammich S; Mackenzie IR; Forné I; Zilow S; Kretzschmar H; Edbauer D; Janssens J; Kleinberger G; Cruts M; Herms J; Neumann M; Van Broeckhoven C; Arzberger T; Haass C
Acta Neuropathol; 2013 Mar; 125(3):413-23. PubMed ID: 23381195
[TBL] [Abstract][Full Text] [Related]
43. TDP-43 N-terminal domain dimerisation or spatial separation by RNA binding decreases its propensity to aggregate.
Miura M; Sakaue F; Matsuno H; Morita K; Yoshida A; Hara RI; Nishimura R; Nishida Y; Yokogawa M; Osawa M; Yokota T
FEBS Lett; 2023 Jun; 597(12):1667-1676. PubMed ID: 37177801
[TBL] [Abstract][Full Text] [Related]
44. Absence of heterogeneous nuclear ribonucleoproteins and survival motor neuron protein in TDP-43 positive inclusions in frontotemporal lobar degeneration.
Neumann M; Igaz LM; Kwong LK; Nakashima-Yasuda H; Kolb SJ; Dreyfuss G; Kretzschmar HA; Trojanowski JQ; Lee VM
Acta Neuropathol; 2007 May; 113(5):543-8. PubMed ID: 17415574
[TBL] [Abstract][Full Text] [Related]
45. Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.
Freibaum BD; Chitta RK; High AA; Taylor JP
J Proteome Res; 2010 Feb; 9(2):1104-20. PubMed ID: 20020773
[TBL] [Abstract][Full Text] [Related]
46. Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards.
Seyfried NT; Gozal YM; Donovan LE; Herskowitz JH; Dammer EB; Xia Q; Ku L; Chang J; Duong DM; Rees HD; Cooper DS; Glass JD; Gearing M; Tansey MG; Lah JJ; Feng Y; Levey AI; Peng J
J Proteome Res; 2012 May; 11(5):2721-38. PubMed ID: 22416763
[TBL] [Abstract][Full Text] [Related]
47. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Arai T; Hasegawa M; Akiyama H; Ikeda K; Nonaka T; Mori H; Mann D; Tsuchiya K; Yoshida M; Hashizume Y; Oda T
Biochem Biophys Res Commun; 2006 Dec; 351(3):602-11. PubMed ID: 17084815
[TBL] [Abstract][Full Text] [Related]
48. The role of mutant TAR DNA-binding protein 43 in amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Janssens J; Kleinberger G; Wils H; Van Broeckhoven C
Biochem Soc Trans; 2011 Aug; 39(4):954-9. PubMed ID: 21787329
[TBL] [Abstract][Full Text] [Related]
49. [TDP-43 proteinopathies: ALS and frontotemporal dementias].
Prudlo J
Fortschr Neurol Psychiatr; 2009 Aug; 77 Suppl 1():S25-7. PubMed ID: 19685386
[TBL] [Abstract][Full Text] [Related]
50. FUS regulates genes coding for RNA-binding proteins in neurons by binding to their highly conserved introns.
Nakaya T; Alexiou P; Maragkakis M; Chang A; Mourelatos Z
RNA; 2013 Apr; 19(4):498-509. PubMed ID: 23389473
[TBL] [Abstract][Full Text] [Related]
51. [Component of ubiquitin-positive inclusions in ALS].
Hasegawa M; Arai T
Brain Nerve; 2007 Oct; 59(10):1171-7. PubMed ID: 17969358
[TBL] [Abstract][Full Text] [Related]
52. Enhancement of native and phosphorylated TDP-43 immunoreactivity by proteinase K treatment following autoclave heating.
Mori F; Tanji K; Kakita A; Takahashi H; Wakabayashi K
Neuropathology; 2011 Aug; 31(4):401-4. PubMed ID: 21175864
[TBL] [Abstract][Full Text] [Related]
53. [The molecular mechanisms of intracellular TDP-43 aggregates].
Nonaka T; Arai T; Hasegawa M
Brain Nerve; 2009 Nov; 61(11):1292-300. PubMed ID: 19938686
[TBL] [Abstract][Full Text] [Related]
54. TDP-43: a DNA and RNA binding protein with roles in neurodegenerative diseases.
Warraich ST; Yang S; Nicholson GA; Blair IP
Int J Biochem Cell Biol; 2010 Oct; 42(10):1606-9. PubMed ID: 20601083
[TBL] [Abstract][Full Text] [Related]
55. Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis.
Bakkar N; Kovalik T; Lorenzini I; Spangler S; Lacoste A; Sponaugle K; Ferrante P; Argentinis E; Sattler R; Bowser R
Acta Neuropathol; 2018 Feb; 135(2):227-247. PubMed ID: 29134320
[TBL] [Abstract][Full Text] [Related]
56. Autophagy receptor defects and ALS-FTLD.
Majcher V; Goode A; James V; Layfield R
Mol Cell Neurosci; 2015 May; 66(Pt A):43-52. PubMed ID: 25683489
[TBL] [Abstract][Full Text] [Related]
57. RNA-Binding Proteins in Amyotrophic Lateral Sclerosis.
Zhao M; Kim JR; van Bruggen R; Park J
Mol Cells; 2018 Sep; 41(9):818-829. PubMed ID: 30157547
[TBL] [Abstract][Full Text] [Related]
58. ALS Associated Mutations in Matrin 3 Alter Protein-Protein Interactions and Impede mRNA Nuclear Export.
Boehringer A; Garcia-Mansfield K; Singh G; Bakkar N; Pirrotte P; Bowser R
Sci Rep; 2017 Nov; 7(1):14529. PubMed ID: 29109432
[TBL] [Abstract][Full Text] [Related]
59. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models.
Tan Q; Yalamanchili HK; Park J; De Maio A; Lu HC; Wan YW; White JJ; Bondar VV; Sayegh LS; Liu X; Gao Y; Sillitoe RV; Orr HT; Liu Z; Zoghbi HY
Hum Mol Genet; 2016 Dec; 25(23):5083-5093. PubMed ID: 28007900
[TBL] [Abstract][Full Text] [Related]
60. Loss of fused in sarcoma (FUS) promotes pathological Tau splicing.
Orozco D; Tahirovic S; Rentzsch K; Schwenk BM; Haass C; Edbauer D
EMBO Rep; 2012 Aug; 13(8):759-64. PubMed ID: 22710833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
